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Abstract
Background: The adrenal gland is one of the common sites of metastasis from primary lung
cancer. Adrenal metastases are usually unilateral however bilateral adrenal metastases are seen in
10% of all lung cancer patients; of these 2–3% occurs at the initial presentation of non-small cell
lung cancer. Secondary tumors can disrupt the structure and function of the adrenal. This can lead
to adrenal hemorrhage, which constitutes a life threatening hazard for the patient.
Case presentation: A 59-year-old male presented with persisting abdominal pain. His initial
work-up revealed significant anemia, an invasive process in the right upper lobe of the lung and large
masses of heterogeneous texture, with hemorrhagic and necrotic elements in both adrenal glands.
A biopsy confirmed it to be a large-cell carcinoma of the lungs. The patient developed severe
leukocytosis akin to the paraneoplastic syndrome and died suddenly five days after the
administration of chemotherapy.
Conclusion:  Intratumoral hemorrhage is a rare but life threatening complication of adrenal
metastases and should be treated as soon as it has been diagnosed. If adrenalectomy is not feasible,
combination chemotherapy should be applied as in metastatic disease. For choosing the
appropriate chemotherapeutic regimen it is important to accurately achieve the diagnosis.
Background
The adrenal gland is a common site for metastases in
breast, lung and renal cell carcinomas, melanoma, and
lymphoma [1]. Adrenal metastasis, at the initial diagnosis
of non-small cell lung cancer, occurs in less than 10% of
lung cancer patients [2]. Most cases involve solitary, uni-
lateral, small asymptomatic lesions, incidentally discov-
ered by CT-scan of the upper abdomen during a staging
evaluation. Bilateral adrenal metastases are observed in
less than 3% of patients with lung cancer. Again, most
cases involve small, asymptomatic lesions. Intratumoral
hemorrhage is a rare but serious complication of adrenal
metastases. We report a case of non-small cell lung cancer
with large bilateral adrenal metastases complicated with
intratumoral hemorrhage and paraneoplastic leukemoid
reaction.
Case presentation
A 59-year-old male, working in a quarry, was admitted to
the hospital complaining of abdominal pain persisting for
45 days, afternoon fever, fatigue and 8 kg weight loss
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during the last month. Previous medical history was non
contributory. He was a heavy smoker for 45 years.
At first assessment, the patient presented with dissemi-
nated dry rales and decrease of vesicular murmur in the
right upper lung field. Following abdominal examination,
palpable smooth surface masses were discovered in both
renal areas. Laboratory tests demonstrated a significant
anemia with normocytic features (hematocrit 24%, Hb
7.2 mg/dl).
Chest X-ray revealed a consolidated area in the right upper
lobe of the lung. Abdomen ultrasound demonstrated
large masses with foci of hemorrhagic necrosis in both
adrenal glands (Figure 1).
Computed tomographic (CT) -scan revealed an invasive
process in the right upper lobe of the lung (Figure 2) and
large masses of heterogeneous texture, with hemorrhagic
and necrotic elements within both adrenal glands (Figure
3).
Magnetic resonance imaging (MRI) was performed which
showed the masses with disseminated foci of high, heter-
ogeneous signal intensity and pathologic enhancement
after intravenous (i.v.) administration of contrast agent in
both T1 and T2 weighted sequences. Radiological features
were suggestive of adrenal metastasis from lung primary
(Figures 4, 5). Histological examination of the biopsy
specimen confirmed the diagnosis of a large-cell carci-
noma of the lung. The patient showed significant deterio-
ration and was hospitalized again for altered level of
consciousness, blurring of vision, tinnitus, lability and
intense fatigue. Laboratory examination demonstrated
severe leukocytosis with 98,000 polymorphonuclear leu-
kocytes, compatible with the leukemoid reaction within
the framework of a paraneoplastic syndrome. Hematocrit
(Ht) levels dropped significantly a second time (Ht: 21%,
Abdomen ultrasound showing large masses with foci of hemorrhagic necrosis in both adrenal glands Figure 1
Abdomen ultrasound showing large masses with foci of hemorrhagic necrosis in both adrenal glands.World Journal of Surgical Oncology 2004, 2:37 http://www.wjso.com/content/2/1/37
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Hb: 6.9 mg/dl), the biochemical parameters were normal,
while the adrenocorticotropic hormone (ACTH)
stimulation test excluded the possibility of cortical adre-
nal failure (serum cortisol basal value: 9µg/dl and 34µg/
dl six hours following intramuscular (i.m.) administra-
tion of 1 mg of ACTH). A repeat abdominal ultrasound
revealed numerous hemorrhagic elements inside the adre-
nal masses. The patient received urgent chemotherapy
with paclitaxel and carboplatin, with simultaneous sup-
portive treatment. Following chemotherapy, leukocytes
decreased progressively, while symptoms related to the
central nervous system (CNS) improved, however, the
patient died suddenly on the fifth day following chemo-
therapy. Autopsy was not performed. The physician's on-
call medical report documented a typical cardiac arrest,
without evidence of acute hemorrhage in adrenal mass.
Discussion
Adrenal metastases in the natural history of a malignant
neoplasm occur in 20 – 45% of cancer patients, depend-
ing on the localization of the primary site [3]. Up to 40%
of patients with non-small cell lung cancer develop unilat-
eral or bilateral adrenal metastases, as the carcinoma
progresses [4].
The differential diagnosis of an adrenal mass incidentally
discovered during imaging examination of the abdomen
in patients with non-small cell lung cancer, usually com-
prises one or more of the characteristics detailed in Table
1.
More than 90% of the cases comprising this involve a
nonfunctional adenoma or an adrenal metastasis.
CT-scan of the chest showing a 60 × 53 mm invasive process in the right upper lobe of the lung Figure 2
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CT-scan of the abdomen showing large masses (98 × 85 mm  right and 90 × 65 mm left) of heterogeneous texture, with  hemorrhagic and necrotic elements within both adrenal  glands Figure 3
CT-scan of the abdomen showing large masses (98 × 85 mm 
right and 90 × 65 mm left) of heterogeneous texture, with 
hemorrhagic and necrotic elements within both adrenal 
glands.
T2 weighted MR image showing disseminated foci of high heterogeneous signal intensity Figure 4
T2 weighted MR image showing disseminated foci of high heterogeneous signal intensity.World Journal of Surgical Oncology 2004, 2:37 http://www.wjso.com/content/2/1/37
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Nonfunctional adenomas can be distinguished from adre-
nal metastasis with precision using modern imaging
techniques, especially with MR imaging, where adenoma
presents a low intensity signals in T2 sequences compared
to hepatic parenchyma. In contrast, the adrenal metastasis
presents higher intensity T2 sequence signals than that of
the adenoma, relative to hepatic parenchyma. In CT-scan
adenoma presents low intensity signals, below 10
Hounsfield units, compared to higher intensity signals in
adrenal metastasis. Porte et al, observed that CT-scan tech-
nology has low specificity and sensitivity, which culmi-
nates in false positive and negative readings, given that
21% of true adenomas can be mistaken for metastases
(density > 10 Hounsfield units) and 11% of true metas-
tases may be mistaken for adenomas (density < 10 Houns-
field units) [5]. CT-scan has 100% sensitivity in detecting
the metastatic nature of adrenal masses; however, 50% of
adenomas may be mistaken as metastasis. Diagnostic
accuracy of adrenal metastasis typically increased with
detection of a primary tumor, as well as changes in the size
and architecture of the parenchyma over time or during
treatment. In equivocal cases, CT-scan-guided percutane-
ous biopsy of the adrenal mass is a safe and reliable
method for the diagnosis of the lesion (sensitivity 81%,
specificity 99%, potential complications 2.8%) [6].
T1 weighted MR image showing enhancement after i.v. administration of contrast agent Figure 5
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In presence of adrenal metastasis the disease is staged as
stage IV, which demonstrates the aggressive biological
behavior and systemic dissemination of secondary
lesions. These are treated as any other metastatic neo-
plasm and the appropriate chemotherapy is started. In
select patients, where the primary lung site is surgically
resectable (T1, T2 and maybe T3), with no involvement or
the involvement of only the peribronchial and portal
lymph nodes (N0, N1) and where the adrenal metastasis
constitutes the unique indication of the disease, simulta-
neous adrenalectomy along with resection of the primary
can increase overall survival [7]. Technically, this can be
achieved with thoracoabdominal or transabdominal
approaches, or laparoscopically in cases of small tumors
(< 5 cm), [8]. A recent meta-analysis suggests that the lat-
ter technique, when it is feasible, is associated with fewer
complications than open adrenalectomy [9]. However,
adrenal metastases are usually larger than 5 cm, as in our
case, which makes this approach inappropriate for general
application. There is also a perceived increased risk of
local tumor recurrence and intraperitoneal tumor dissem-
ination occurring after laparoscopic resection of malig-
nant adrenal tumors [10].
The most important complication of adrenal metastases is
intratumoral hemorrhage and only nine cases have been
reported previously [11]. When hemorrhage risk is high,
as in the case of large metastasis, timely adrenalectomy is
a necessary intervention. For resecting larger adrenal
tumors in presence of bilateral involvement the transab-
dominal approach with extended subcostal incision
(Kocher) is preferred. When this is considered technically
impossible, radiation therapy can be an alternative pallia-
tive approach. During the course of the disease, our
patient developed a leukemoid reaction and the perform-
ance status dropped remarkably, making it difficult to
proceed with the planned surgical resection. Thus, the
paclitaxel and carboplatin chemotherapeutic regimen was
administered in an attempt to decrease the leucocytes
count and improve the CNS symptoms. Even though the
infusion of paclitaxel has been associated with cardiovas-
cular events, there is no clear relation between the drug
administration and the sudden death of our patient.
A less common complication of bilateral adrenal metas-
tases is primary adrenal insufficiency, caused by the
destruction of adrenal gland architecture and function
due to the development of the tumor. The main symp-
toms resulting from the decreased production of steroid
hormones often overlap with the general indicators
caused by the primary site, hindering the proper treatment
of these patients. Primary adrenal insufficiency is diag-
nosed when serum cortisol basal values are low (<5µg/dl),
and particularly when the values fail to increase within six
hours following the i.m. administration of 1 mg of tetra-
cosactride, the synthetic analog of ACTH. The treatment
comprises daily administration of glucocorticoid and
mineralocorticoid for life.
Conclusion
Bilateral adrenal metastases can be found in a small
number of patients with non-small cell lung cancer. Early
identification of these lesions is necessary, since adrenal-
ectomy may increase survival in select patients. Intratu-
moral hemorrhage is a rare but life threatening
complication and should be treated as soon as it has been
diagnosed. If adrenalectomy is not feasible, combination
chemotherapy should be applied.
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